FDA expands recall of blood pressure tablets over dissolution failures

FDA expands recall of blood pressure tablets over dissolution failures

Health
Sign in to pin this event

The U. S. Food and Drug Administration recalled more than 3,700 bottles of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets in the United States on November 3 after quality testing showed the tablets failed to dissolve properly.

The recall follows an earlier action on October 26, when the agency announced a voluntary Class III recall of more than 21,000 bottles of telmisartan and amlodipine tablets because of potency concerns. The agency later classified the November 3 recall as a Class II recall, citing the failed dissolution specifications.

Actors

U.S. Food and Drug Administration Mylan Pharmaceuticals

Locations

United States

Articles

November 03, 2026
4 total
Macleods Pharma USA recalls over 3,700 bottles of blood pressure pills
Macleods Pharma USA recalls over 3,700 bottles of blood pressure pills

Newsday • 03 Nov 19:23

The FDA classified the recall as Class II after a quality test showed the generic Olmesartan-Amlodipine-Hydrochlorothiazide tablets failed dissolution specifications.

Credibility 92% Manip. 5% Center
FDA issues nationwide recall of blood pressure medication bottles
FDA issues nationwide recall of blood pressure medication bottles

WGAL • 03 Nov 10:35

The U.S. Food and Drug Administration has recalled over 3,700 bottles of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets after quality testing showed they did not dissolve properly.

Credibility 92% Manip. 5% Center
FDA issues nationwide recall of blood pressure medication bottles
FDA issues nationwide recall of blood pressure medication bottles

WCVB • 03 Nov 10:12

The U.S. Food and Drug Administration has recalled over 3,700 bottles of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets after quality testing showed they did not dissolve properly.

Credibility 92% Manip. 5% Center
FDA issues nationwide recall of blood pressure medication bottles
FDA issues nationwide recall of blood pressure medication bottles

WMUR • 03 Nov 10:12

The U.S. Food and Drug Administration has recalled over 3,700 bottles of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets after quality testing showed they did not dissolve properly.

Credibility 92% Manip. 5% Center
November 02, 2026
2 total
Macleods Pharma USA Recalls Thousands of Blood Pressure Medication Bottles Nationwide
Macleods Pharma USA Recalls Thousands of Blood Pressure Medication Bottles Nationwide

Fox Business • 02 Nov 23:25

Macleods Pharma USA is recalling over 3,700 bottles of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide tablets after the FDA found they failed dissolution testing.

Credibility 92% Manip. 8% Center
FDA issues Class II recall of thousands of generic blood pressure tablets
FDA issues Class II recall of thousands of generic blood pressure tablets

USA Today • 02 Nov 18:37

The Food and Drug Administration has classified a recall of over 3,700 bottles of generic blood-pressure medication as Class II, citing failed dissolution specifications that could reduce effectiveness.

Credibility 92% Manip. 5% Center
October 27, 2026
2 total
FDA Issues Nationwide Recall of Telmisartan and Amlodipine Blood Pressure Pills
FDA Issues Nationwide Recall of Telmisartan and Amlodipine Blood Pressure Pills

Yahoo • 27 Oct 15:10

The U.S. Food and Drug Administration has announced a voluntary Class III recall of more than 21,000 bottles of telmisartan and amlodipine tablets due to potency concerns.

Credibility 78% Manip. 8% Center
FDA Issues Nationwide Recall of Telmisartan and Amlodipine Bottles
FDA Issues Nationwide Recall of Telmisartan and Amlodipine Bottles

EatingWell • 27 Oct 15:10

The U.S. Food and Drug Administration has announced a voluntary Class III recall of more than 21,000 bottles of telmisartan and amlodipine due to dosage potency issues.

Credibility 72% Manip. 8% Center

Related events